Yamane K, Shima T, Nishida M, Hatayama T, Yamanaka C, Toyota A, Hiramatsu K, Ishino S, Okada Y
Department of Neurosurgery, Chugoku Rosai Hospital, 1-5-1 Hirotagaya, Kure 737-0193, Japan.
No Shinkei Geka. 2001 Apr;29(4):307-13.
We studied cerebral circulation in patients with occlusion of the main cerebral artery and investigated the efficacy of STA-MCA anastomosis.
Thirty-six patients with occlusion of the main cerebral artery were studied. Twenty-three patients had occlusion of the internal carotid artery and 13 had occlusion of the middle cerebral artery. The mean age was 62 years. Cerebral blood flow (CBF) was measured in all patients and cerebrovascular reactivity (CVR) was examined in 11 patients by xenon enhanced CT. Intraoperatively, cortical arterial pressure and anastomotic flow were measured.
There was no perioperative mortality or morbidity. There was no ipsilateral stroke recurrence during the follow-up period averaging 35.1 months. Patency of the anastomosis was verified in 91% of the patients by magnetic resonance angiography. Twenty-three (64%) patients showed decreased CBF before the operation and 57% of these patients showed improvement to the normal range after STA-MCA anastomosis. All of the eight patients with decreased CVR showed improvement after the operation. Anastomotic flow correlated significantly with the cortical arterial pressure.
STA-MCA anastomosis could improve cerebral circulation of patients with low CBF or low CVR due to occlusion of the main cerebral arterial. It was concluded that STA-MCA anastomosis may contribute to the reduction of stroke recurrence, if perioperative complications are reduced.
我们研究了大脑主要动脉闭塞患者的脑循环,并探讨了颞浅动脉-大脑中动脉(STA-MCA)吻合术的疗效。
对36例大脑主要动脉闭塞患者进行了研究。其中23例为颈内动脉闭塞,13例为大脑中动脉闭塞。平均年龄为62岁。对所有患者测量了脑血流量(CBF),并通过氙增强CT对11例患者检查了脑血管反应性(CVR)。术中测量了皮质动脉压和吻合口血流量。
围手术期无死亡或并发症发生。在平均35.1个月的随访期内,同侧无卒中复发。通过磁共振血管造影证实91%的患者吻合口通畅。23例(64%)患者术前CBF降低,其中57%的患者在STA-MCA吻合术后CBF改善至正常范围。所有8例CVR降低的患者术后均有改善。吻合口血流量与皮质动脉压显著相关。
STA-MCA吻合术可改善因大脑主要动脉闭塞导致CBF或CVR降低患者的脑循环。得出的结论是,如果减少围手术期并发症,STA-MCA吻合术可能有助于降低卒中复发率。